| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |